|
17/05/2012 |
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting |
 |
|
04/05/2012 |
MorphoSys AG Reports Results for the First Quarter of 2012 |
|
|
18/04/2012 |
MorphoSys Nominates Karin Eastham and Marc Cluzel as New Supervisory Board Members |
|
|
02/04/2012 |
MorphoSys to Start Share Buy-Back Program |
|
|
28/03/2012 |
MorphoSys Announces Clinical Milestone from Strategic Alliance |
|
|
15/03/2012 |
AbD Serotec Expands Range of HuCAL Antibodies Used in Clinical Diagnostic Kits |
|
|
06/03/2012 |
MorphoSys Completes Enrollment in MOR103 Phase 1b/2a Rheumatoid Arthritis Trial |
|
|
01/03/2012 |
MorphoSys AG Reports Record Results for Fiscal Year 2011 |
|
|
27/02/2012 |
MorphoSys Signs Three-Year Protein Engineering Alliance on Slonomics Technology |
|
|
23/01/2012 |
MorphoSys Strengthens Patent Position on MOR202 Program |
|
|
21/12/2011 |
MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients with Multiple Sclerosis |
|
|
15/12/2011 |
MorphoSys and Novozymes Sign Long-Term Alliance on Slonomics® Technology for Industrial Biotechnology Applications |
|
